1 and Kyoto Nianci _ have not been removed from the shelves. According to statistics, Kyoto Nianci _ series products are the products with the largest sales volume and the highest share among cough products imported from the mainland of China, accounting for more than 95% of the market share of Chinese patent medicines imported from the mainland of China.

2. Jinhao Pharmaceutical Group, a listed company in Hong Kong, has signed an agency cooperation agreement with Kyoto Nianci General Factory since 1997 to sell Kyoto Nianci _ honey-refined Chuanbei loquat cream on the mainland of China, and other products such as Nianci _ loquat sugar were introduced later.

3. Nianci _ Chuanbei Pipa Cream is very important to Jinhuo Pharmaceutical Group, accounting for 70% of its revenue at one time. As Jinhuo Pharmaceutical Group increased its product layout, the sales of Nianci _ Chuanbei Pipa Cream decreased in recent years. By 20 19, the revenue of the company's Kyoto Nianci _ Chuanbei Pipa Cream decreased by 14.3% year-on-year.

4. At the beginning of 20 18, the flu was rampant in the United States, and the traditional cough syrup "Kyoto Nianci Chuanbei Pipa Cream" in China was very popular in the United States, and the price of a bottle of 7 dollars was fried to 70 dollars. The share price of Jinhuo Pharmaceutical Group also rose.